1. Home
  2. Approved trials
  3. » فارسی

Study of the effect of Sinamaz on the prevention of‏ ‏upper respiratory diseases (URD) ‎among Iranian arbaeen Pilgrims

View the latest revision

History
# Registration date Revision Id
2 2024-09-11, 1403/06/21 314166
1 2023-05-24, 1402/03/03 265724
Changes made to previous revision

  • Help:

    Red color represents old content. It may be empty showing addition in the new version.
    Green color represents new content. It may be empty showing deletion in the new version.

    Inline Side by side
    Added new contents, deleted old contents, contents that are not changed.
    New table contents New table contents
    Old table contents Old table contents
    Unchanged contents Unchanged contents
    Added new contents, contents that are not changed.
    Deleted old contents, contents that are not changed.
    Old table contents Old table contents
    Unchanged contents Unchanged contents
    New table contents New table contents
    Unchanged contents Unchanged contents

  • Protocol summary

    Study of the effect of Sinamaz on the prevention of‏ ‏upper respiratory diseases (URD) ‎among Iranian Hajj Pilgrims
    Study of the effect of Sinamaz on the prevention of‏ ‏upper respiratory diseases (URD) ‎among Iranian Arbaeen Pilgrims
    بررسی تأثیر داروی سیناماز در پیشگیری از بیماری های تنفسی فوقانی ‏‎(URD) ‎‏ در زائران ایرانی حج
    بررسی تأثیر داروی سیناماز در پیشگیری از بیماری های تنفسی فوقانی ‏‎(URD) ‎‏ در زائران ایرانی اربعین
    This study is a double-blind, randomized, placebo-controlled clinical trial on 180 healthy Iranian ‎Hajj Pilgrims. 180 codes were randomized with Excel software.‎
    This study is a double-blind, randomized, placebo-controlled clinical trial on 180 healthy Iranian Arbaeen Pilgrims. 180 codes were randomized with Excel software.‎
    این مطالعه به صورت یک کارآزمایی بالینی دوسوکور، تصادفی شده و کنترل شده با دارونما بر روی 180 زائر حج تمتع سالم‎ ‎‏ می باشد. ‏تصادفی سازی 180 کد با نرم افزار اکسل انجام شد‎.‎
    این مطالعه به صورت یک کارآزمایی بالینی دوسوکور، تصادفی شده و کنترل شده با دارونما بر روی 180 زائر اربعین سالم‎ ‎‏ می باشد. ‏تصادفی سازی 180 کد با نرم افزار اکسل انجام شد‎.‎
    The informed consent form is signed by the candidates participating in the study or their legal ‎guardians if they have not reached the legal age‏.‏‎ Relevant questionnaires are completed. Sinamaz ‎and placebo are provided by the manufacturer with similar containers. Special codes are inserted on ‎the package that will be kept confidential until the end of the study. Healthy Iranian Hajj Pilgrims ‎use one drop ‎in each side of their nose twice a day for 5 weeks. The questionnaire is completed on ‎days 0, 14, 28, and The end of the trip
    The informed consent form is signed by the candidates participating in the study or their legal ‎guardians if they have not reached the legal age‏.‏‎ Relevant questionnaires are completed. Sinamaz ‎and placebo are provided by the manufacturer with similar containers. Special codes are inserted on ‎the package that will be kept confidential until the end of the study. Healthy Iranian Arbaeen Pilgrims ‎use one drop ‎in each side of their nose twice a day for 1 week. The questionnaire is completed on ‎days 0 and The end of the trip
    فرم رضایت آگاهانه توسط داوطلبین شرکت در مطالعه و یا ولی قانونی آنان در صورتی به سن ‏قانونی نرسیده باشند‏ امضا می شود. ‏ ‏پرسشنامه‌های مربوطه تکمیل می‌شود. دارو، دارونما از شرکت تولید کننده بدون برچسب با ظرف‌های مشابه تهیه می‌شود. کدهای مخصوص ‏روی بسته بندی درج می شود که تا پایان مطالعه به‌صورت محرمانه نگهداری خواهد شد‎.‎‏ زائران حج تمتع سالم، به مدت 5 هفته و در طی ‏هر روز، 2 بار یک قطره در هر سمت بینی می چکانند (2 بار در روز). روزهای‎ ‎صفر،‎ ‎‏14،‎ ‎‏28و پایان ‏سفر ‏‎ ‎پرسشنامه‎ ‎تکمیل‎ ‎می‎ ‎شود.‏
    فرم رضایت آگاهانه توسط داوطلبین شرکت در مطالعه و یا ولی قانونی آنان در صورتی به سن ‏قانونی نرسیده باشند‏ امضا می شود. ‏ ‏پرسشنامه‌های مربوطه تکمیل می‌شود. دارو، دارونما از شرکت تولید کننده بدون برچسب با ظرف‌های مشابه تهیه می‌شود. کدهای مخصوص ‏روی بسته بندی درج می شود که تا پایان مطالعه به‌صورت محرمانه نگهداری خواهد شد‎.‎‏ زائران اربعین سالم، به مدت 1 هفته و در طی ‏هر روز، 2 بار یک قطره در هر سمت بینی می چکانند (2 بار در روز). روزهای‎ ‎صفر و پایان ‏سفر ‏‎ ‎پرسشنامه‎ ‎تکمیل‎ ‎می‎ ‎شود.‏
    90 healthy Iranian Hajj Pilgrims use one drop of Cinnamase oil ‎in each side of their nose twice a day for 5 weeks. Sinamaz drops (License number: 118880/665)‎is the product of "Sanabel Daroo" company. This drug is a product derived from the knowledge of Iranian traditional medicine, which is scientifically prepared from Nigella sativa L. oil and Olea europaea L oil. Control group: 90 healthy Iranian Hajj Pilgrims use one drop of placebo ‎in each side of their nose twice a ‎day for 5 weeks. ‎
    90 healthy Iranian َArbaeen Pilgrims use one drop of Cinnamase oil ‎in each side of their nose twice a day for 1 week. Sinamaz drops (License number: 118880/665)‎is the product of "Sanabel Daroo" company. This drug is a product derived from the knowledge of Iranian traditional medicine, which is scientifically prepared from Nigella sativa L. oil and Olea europaea L oil. Control group: 90 healthy Iranian Hajj Pilgrims use one drop of placebo ‎on each side of their nose twice a ‎day for 1 week. ‎
    تعداد 90 نفر، از زائران حج تمتع سالم، به مدت 5 هفته و در طی هر روز، 2 بار یک قطره از ‏روغن سیناماز را در هر سمت بینی می ‏چکانند (2 بار در روز). قطره‎ ‎سیناماز (شماره مجوز: ‏‎118880/665‎‏ ‏‎(‎ ‎محصول‎ ‎شرکت‎ ‎‎"‎سنابل‎ ‎دارو‎" ‎میباشد‎. ‎ا‎ ‎ین‎ ‎دارو،‎ ‎محصولی‎ ‎است‎ ‎برگرفته‎ ‎از‎ ‎دانش‎ ‎طب‎ ‎سنتی‎ ‎ایرانی‎ ‎کهبه‎ ‎طور‎ ‎علمی‎ ‎از‎ ‎روغن‎ . Nigella sativa ‎L ‎و‎ ‎روغن‎ Oleaeuropaea L. ‎تهیه‎ ‎شده‎ است.‎گروه کنترل: تعداد 90 نفر، از زائران حج تمتع سالم، به مدت 5 هفته و در طی هر روز، 2 بار یک قطره دارونما را در هر سمت بینی می ‏چکانند (2 بار در روز).
    تعداد 90 نفر، از زائران اربعین سالم، به مدت 1 هفته و در طی هر روز، 2 بار یک قطره از ‏روغن سیناماز را در هر سمت بینی می ‏چکانند (2 بار در روز). قطره‎ ‎سیناماز (شماره مجوز: ‏‎118880/665‎‏ ‏‎(‎ ‎محصول‎ ‎شرکت‎ ‎‎"‎سنابل‎ ‎دارو‎" ‎میباشد‎. ‎ا‎ ‎ین‎ ‎دارو،‎ ‎محصولی‎ ‎است‎ ‎برگرفته‎ ‎از‎ ‎دانش‎ ‎طب‎ ‎سنتی‎ ‎ایرانی‎ ‎کهبه‎ ‎طور‎ ‎علمی‎ ‎از‎ ‎روغن‎ . Nigella sativa ‎L ‎و‎ ‎روغن‎ Olea europaea L. ‎تهیه‎ ‎شده‎ است.‎گروه کنترل: تعداد 90 نفر، از زائران حج تمتع سالم، به مدت 1 هفته و در طی هر روز، 2 بار یک قطره دارونما را در هر سمت بینی می ‏چکانند (2 بار در روز).

  • General information

    2023-05-24, 1402/03/03
    2023-07-23, 1402/05/01
    2024-07-22, 1403/05/01
    2025-08-11, 1404/05/20
    empty
    The doctors could not fill out the questionnaires.
    empty
    پزشکان نتوانستند پرسشنامه ها را پر کنند.
    The effect of Sinamaz drops on the prevention of‏ ‏upper respiratory diseases ‎among Iranian Hajj Pilgrims.
    The effect of Sinamaz drops on the prevention of‏ ‏upper respiratory diseases ‎among Iranian arbaeen Pilgrims
    اثر قطره سیناماز بر پیشگیری از بیماری های تنفسی فوقانی ‏‎در زائران ایرانی حج
    اثر قطره سیناماز بر پیشگیری از بیماری های تنفسی فوقانی ‏‎در زائران ایرانی اربعین
    Study of the effect of Sinamaz on the prevention of‏ ‏upper respiratory diseases (URD) ‎among Iranian Hajj Pilgrims
    Study of the effect of Sinamaz on the prevention of‏ ‏upper respiratory diseases (URD) ‎among Iranian arbaeen Pilgrims
    بررسی تأثیر داروی سیناماز در پیشگیری از بیماری های تنفسی فوقانی ‏‎(URD) ‎‏ در زائران ایرانی حج
    بررسی تأثیر داروی سیناماز در پیشگیری از بیماری های تنفسی فوقانی ‏‎(URD) ‎‏ در زائران ایرانی اربعین

  • Primary outcomes

    #1
    The questionnaire is completed on days 0, 14, 28, and The end of the trip
    The questionnaire is completed on days 0, 3 and 7.
    روزهای‎ ‎صفر،‎ ‎‏14،‎ ‎‏28و پایان سفر ‏‎ ‎پرسشنامه‎ ‎تکمیل‎ ‎می‎ ‎شود.‏
    روزهای‎ ‎0, 3و7‏‎ ‎پرسشنامه‎ ‎تکمیل‎ ‎می‎ ‎شود.‏

  • Intervention groups

    #1
    Intervention group: 90 healthy Iranian Hajj Pilgrims use one drop of Cinnamase oil ‎in each side of their nose twice a day for 5 weeks. The questionnaire is completed on days 0, 14, 28, and The end of the trip. Sinamaz drops (License number: 118880/665)‎is the product of "Sanabel Daroo" company. This drug is a product derived from the knowledge of Iranian traditional medicine, which is scientifically prepared from Nigella sativa L. oil and Olea europaea L oil.‎
    Intervention group: 90 healthy Iranian Arbaeen Pilgrims use one drop of Cinnamase oil ‎in each side of their nose twice a day for 1 week. The questionnaire is completed on days 0, 3, and 7. Sinamaz drops (License number: 118880/665)‎is the product of "Sanabel Daroo" company. This drug is a product derived from the knowledge of Iranian traditional medicine, which is scientifically prepared from Nigella sativa L. oil and Olea europaea L oil.‎
    گروه مداخله: تعداد 90 نفر، از زائران حج تمتع سالم، به مدت 5 هفته و در طی هر روز، 2 بار یک قطره از ‏روغن سیناماز را در هر سمت بینی می چکانند (2 بار در روز). روزهای‎ ‎صفر،‎ ‎‏14،‎ ‎‏28و پایان سفر ‏‎ ‎پرسشنامه‎ ‎تکمیل‎ ‎می‎ ‎شود. قطره‎ ‎سیناماز (شماره مجوز: ‏‎118880/665‎‏ ‏‎(‎ محصول‎ ‎شرکت‎ "‎سنابل‎ ‎دارو‎" ‎میباشد‎. ‎ا‎ ‎ین‎ ‎دارو،‎ ‎محصولی‎ ‎است‎ ‎برگرفته‎ ‎از‎ ‎دانش‎ ‎طب‎ ‎سنتی‎ ‎ایرانی‎ ‎که به‎ ‎طور‎ ‎علمی‎ ‎از‎ ‎روغن‎ . Nigella sativa L ‎و‎ ‎روغن‎ Oleaeuropaea L. ‎تهیه‎ ‎شده‎ ‎است‎.‎
    گروه مداخله: تعداد 90 نفر، از زائران اربعین سالم، به مدت 1 هفته و در طی هر روز، 2 بار یک قطره از ‏روغن سیناماز را در هر سمت بینی می چکانند (2 بار در روز). روزهای‎ 0‎ ‎‏، 3 و 7 ‏‎ ‎پرسشنامه‎ ‎تکمیل‎ ‎می‎ ‎شود. قطره‎ ‎سیناماز (شماره مجوز: ‏‎118880/665‎‏ ‏‎(‎ محصول‎ ‎شرکت‎ "‎سنابل‎ ‎دارو‎" ‎میباشد‎. ‎ا‎ ‎ین‎ ‎دارو،‎ ‎محصولی‎ ‎است‎ ‎برگرفته‎ ‎از‎ ‎دانش‎ ‎طب‎ ‎سنتی‎ ‎ایرانی‎ ‎که به‎ ‎طور‎ ‎علمی‎ ‎از‎ ‎روغن‎ . Nigella sativa L ‎و‎ ‎روغن‎ Oleaeuropaea L. ‎تهیه‎ ‎شده‎ ‎است‎.‎
    #2
    90 healthy Iranian Hajj Pilgrims use one drop of placebo ‎in each side of their nose twice a ‎day for 5 weeks. The ‎questionnaire is completed on days 0, 14, 28, and The end of the trip
    90 healthy Iranian Arbaeen Pilgrims use one placebo drop ‎on each side of their nose twice a ‎day for 1 week. The ‎questionnaire is completed on days 0 and 3, 7.
    تعداد 90 نفر، از زائران حج تمتع سالم، به مدت 5 هفته و در طی هر روز، 2 بار یک قطره دارونما را در هر سمت بینی می ‏چکانند (2 بار در روز). روزهای‏‎ ‎صفر،‎ ‎‏14،‎ ‎‏28و پایان سفر ‏‎ ‎پرسشنامه‎ ‎تکمیل‎ ‎می‎ ‎شود.‏
    تعداد 90 نفر، از زائران اربعین سالم، به مدت 1 هفته و در طی هر روز، 2 بار یک قطره دارونما را در هر سمت بینی می ‏چکانند (2 بار در روز). روزهای‏‎ 0و 3و 7 ‏‎ ‎پرسشنامه‎ ‎تکمیل‎ ‎می‎ ‎شود.‏

  • Recruitment centers

    #1
    Name of recruitment center - English: Iranian Red Crescent Clinic
    Name of recruitment center - Persian: درمانگاه هلال احمر ایران
    Full name of responsible person - English: محسن ناصری
    Full name of responsible person - Persian: Mohsen Naseri
    Street address - English: No.1471, North Kargar Street, Enghelab Square,Tehran , Iran.
    Street address - Persian: میدان‎ ‎انقلاب،‎ ‎خیابان‎ ‎کارگر‎ ‎شمالی،‎ ‎بین‎ ‎فرصت‎ ‎و‎ ‎نصرت،‎ ‎پلاک ‎.1471‎
    City - English: Tehran
    City - Persian: تهران
    Province: Tehran
    Country: Iran (Islamic Republic of)
    Postal code: 1417953836
    Phone: +98 21 6646 4320
    Fax:
    Email: naseri@shahed.ac.ir
    Web page address:
    Name of recruitment center - English: موکب
    Name of recruitment center - Persian: mokeb
    Full name of responsible person - English: Mohsen Naseri
    Full name of responsible person - Persian: محسن ناصری
    Street address - English: No.1471, North Kargar Street, Enghelab Square,Tehran , Iran.
    Street address - Persian: میدان‎ ‎انقلاب،‎ ‎خیابان‎ ‎کارگر‎ ‎شمالی،‎ ‎بین‎ ‎فرصت‎ ‎و‎ ‎نصرت،‎ ‎پلاک ‎.1471‎
    City - English: Tehran
    City - Persian: تهران
    Province: Tehran
    Country: Iran (Islamic Republic of)
    Postal code: 1417953836
    Phone: +98 21 6646 4320
    Fax:
    Email: naseri@shahed.ac.ir
    Web page address:

  • Sponsors / Funding sources

    #1

    Name of organization / entity - English:
    Name of organization / entity - Persian:
    Full name of responsible person - English: Mohsen Naseri
    Full name of responsible person - Persian: محسن ناصری
    Street address - English: No.1471, North Kargar Street, Enghelab Square,Tehran , Iran.
    Street address - Persian: میدان‎ ‎انقلاب،‎ ‎خیابان‎ ‎کارگر‎ ‎شمالی،‎ ‎بین‎ ‎فرصت‎ ‎و‎ ‎نصرت،‎ ‎پلاک ‎.1471‎
    City - English: Tehran
    City - Persian: تهران
    Province: Tehran
    Country: Iran (Islamic Republic of)
    Postal code: 1417953836
    Phone: +98 21 6646 4320
    Fax:
    Email: naseri@shahed.ac.ir
    Web page address:

    Name of organization / entity - English:
    Name of organization / entity - Persian:
    Full name of responsible person - English: Shahriar Bijani‎
    Full name of responsible person - Persian: شهریار بیژنی
    Street address - English: Shahed University, In front of the holy shrine of Imam Khomeini, Qom freeway,Tehran , Iran.‎
    Street address - Persian: تهران - ابتدای آزاد راه تهران قم - روبروی حرم مطهر امام خمینی (ره) - دانشگاه شاهد
    City - English: Tehran
    City - Persian: تهران
    Province: Tehran
    Country: Iran (Islamic Republic of)
    Postal code: 3319118651
    Phone: +98 21 5121 5116
    Fax:
    Email: Bijani‎@shahed.ac.ir
    Web page address:

Protocol summary

Study aim
Study of the effect of Sinamaz on the prevention of‏ ‏upper respiratory diseases (URD) ‎among Iranian Arbaeen Pilgrims
Design
This study is a double-blind, randomized, placebo-controlled clinical trial on 180 healthy Iranian Arbaeen Pilgrims. 180 codes were randomized with Excel software.‎
Settings and conduct
The informed consent form is signed by the candidates participating in the study or their legal ‎guardians if they have not reached the legal age‏.‏‎ Relevant questionnaires are completed. Sinamaz ‎and placebo are provided by the manufacturer with similar containers. Special codes are inserted on ‎the package that will be kept confidential until the end of the study. Healthy Iranian Arbaeen Pilgrims ‎use one drop ‎in each side of their nose twice a day for 1 week. The questionnaire is completed on ‎days 0 and The end of the trip
Participants/Inclusion and exclusion criteria
Signing consent forms by volunteers participating in the study; Volunteers should not have respiratory ‎disease symptoms; Volunteers should not participate in other clinical trials; People who are suffering ‎from certain underlying diseases or receiving drugs such as corticosteroids or immunosuppressants nor ‎who have any history of nose or septum surgery are not approved as volunteers.
Intervention groups
90 healthy Iranian َArbaeen Pilgrims use one drop of Cinnamase oil ‎in each side of their nose twice a day for 1 week. Sinamaz drops (License number: 118880/665)‎is the product of "Sanabel Daroo" company. This drug is a product derived from the knowledge of Iranian traditional medicine, which is scientifically prepared from Nigella sativa L. oil and Olea europaea L oil. Control group: 90 healthy Iranian Hajj Pilgrims use one drop of placebo ‎on each side of their nose twice a ‎day for 1 week. ‎
Main outcome variables
Clinical signs of of‏ ‏upper respiratory diseases

General information

Reason for update
The doctors could not fill out the questionnaires.
Acronym
URD
IRCT registration information
IRCT registration number: IRCT20210515051305N2
Registration date: 2023-05-24, 1402/03/03
Registration timing: prospective

Last update: 2024-09-14, 1403/06/24
Update count: 1
Registration date
2023-05-24, 1402/03/03
Registrant information
Name
Zahra Bahaeddin
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 6646 4320
Email address
z.bahaedin@gmail.com
Recruitment status
recruiting
Funding source
Expected recruitment start date
2023-07-23, 1402/05/01
Expected recruitment end date
2025-08-11, 1404/05/20
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Study of the effect of Sinamaz on the prevention of‏ ‏upper respiratory diseases (URD) ‎among Iranian arbaeen Pilgrims
Public title
The effect of Sinamaz drops on the prevention of‏ ‏upper respiratory diseases ‎among Iranian arbaeen Pilgrims
Purpose
Prevention
Inclusion/Exclusion criteria
Inclusion criteria:
Signing consent forms by volunteers participating in the study Volunteers should not have respiratory diseases symptoms Volunteers should not participate in other clinical trials people who are suffering from certain underlying diseases or receiving drugs such as corticosteroids or immunosuppressants nor who have any history of nose or septum surgery are not approved as Volunteers
Exclusion criteria:
Allergy to herbal medicines and and natural oils
Age
No age limit
Gender
Both
Phase
2
Groups that have been masked
  • Participant
  • Care provider
  • Investigator
  • Outcome assessor
Sample size
Target sample size: 180
More than 1 sample in each individual
Number of samples in each individual: 4
Filling the questionnaire
Randomization (investigator's opinion)
Randomized
Randomization description
Eligible participants will be randomly assigned into 2 groups in a 1:1 ratio using a block randomization method with a block length of 2 by PROC PLAN of SAS 9.4. An independent statistician generates the randomization number sequence. The drug codes will be attached after the manufacturing and packaging of the experiment treatment and placebo. The drugs will be allocated sequentially according to the screening order of the patients. Group assignment will be kept in an opaque and sealed envelope and will be opened after data analysis by another statistician.
Blinding (investigator's opinion)
Double blinded
Blinding description
The coding is done in two groups and placebo by a person who does not interfere in the plan and ‎keeps the codes confidential. Until the end of the study, the researcher, doctor and project ‎colleagues are not aware of it.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics Committee of Shahed University
Street address
Shahed University, In front of the holy shrine of Imam Khomeini, Qom freeway,Tehran , Iran.
City
Tehran
Province
Tehran
Postal code
3319118651
Approval date
2023-05-08, 1402/02/18
Ethics committee reference number
IR.SHAHED.REC.1402.001

Health conditions studied

1

Description of health condition studied
Upper respiratory diseases ‎
ICD-10 code
J39
ICD-10 code description
Other diseases of upper respiratory tract

Primary outcomes

1

Description
Clinical signs of of‏ ‏upper respiratory diseases
Timepoint
The questionnaire is completed on days 0, 3 and 7.
Method of measurement
Questionnaire

Secondary outcomes

empty

Intervention groups

1

Description
Intervention group: 90 healthy Iranian Arbaeen Pilgrims use one drop of Cinnamase oil ‎in each side of their nose twice a day for 1 week. The questionnaire is completed on days 0, 3, and 7. Sinamaz drops (License number: 118880/665)‎is the product of "Sanabel Daroo" company. This drug is a product derived from the knowledge of Iranian traditional medicine, which is scientifically prepared from Nigella sativa L. oil and Olea europaea L oil.‎
Category
Treatment - Drugs

2

Description
90 healthy Iranian Arbaeen Pilgrims use one placebo drop ‎on each side of their nose twice a ‎day for 1 week. The ‎questionnaire is completed on days 0 and 3, 7.
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
موکب
Full name of responsible person
Mohsen Naseri
Street address
No.1471, North Kargar Street, Enghelab Square,Tehran , Iran.
City
Tehran
Province
Tehran
Postal code
1417953836
Phone
+98 21 6646 4320
Email
naseri@shahed.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Shahed University
Full name of responsible person
Shahriar Bijani‎
Street address
Shahed University, In front of the holy shrine of Imam Khomeini, Qom freeway,Tehran , Iran.‎
City
Tehran
Province
Tehran
Postal code
3319118651
Phone
+98 21 5121 5116
Email
Bijani‎@shahed.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
No
Title of funding source
Traditional Medicine Clinical Trial Research Center,Shahed University, Tehran, Iran
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Shahed University
Full name of responsible person
Mohsen Naseri
Position
Professor
Latest degree
Ph.D.
Other areas of specialty/work
Traditional Medicine
Street address
No.1471, North Kargar Street, Enghelab Square,Tehran , Iran.
City
Tehran
Province
Tehran
Postal code
1417953836
Phone
+98 21 6646 4320
Email
naserishahed@yahoo.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Shahed University
Full name of responsible person
Mohsen Naseri
Position
Professor
Latest degree
Ph.D.
Other areas of specialty/work
Traditional Medicine
Street address
No.1471, North Kargar Street, Enghelab Square,Tehran , Iran.
City
Tehran
Province
Tehran
Postal code
1417953836
Phone
+98 21 6646 4320
Email
naseri@shahed.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
Shahed University
Full name of responsible person
zahra bahaeddin
Position
Assistant Professor
Latest degree
Ph.D.
Other areas of specialty/work
Traditional Medicine
Street address
No.1471, North Kargar Street, Enghelab Square,Tehran, Iran.
City
tehran
Province
Tehran
Postal code
1417953836
Phone
+98 21 6646 4320
Email
z.bahaedin@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Title and more details about the data/document
Clinical study report: published as an article.‎
When the data will become available and for how long
‎6 months after printing the results in the form of an article
To whom data/document is available
Researchers working in institutions and individuals in the industrial sector can apply to a ‎scientific respondent.
Under which criteria data/document could be used
It is possible to use the documents after publishing the extracted article with a scientifically ‎responsive opinion.‎
From where data/document is obtainable
Email: naseri@shahed.ac.ir naserishahed@yahoo.com
What processes are involved for a request to access data/document
The email will be reviewed by the applicant at least two days after the application is sent and ‎will be answered within a week.‎
Comments
Loading...